Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bighat Biosciences Inc.
Headquarters: San Carlos, CA, United States of America
Website: https://www.bighatbio.com/
Year Founded: 2019
Status: Private
BioCentury | Mar 5, 2025
Management Tracks
CFO Anthony Doyle resigns at Biocryst
Plus: Greenside succeeds CEO Mark DePristo at Bighat, and updates from Be Biopharma, 3t and Imugene
BioCentury | Apr 30, 2024
Deals
Deals Report: BMS-Repertoire to develop vaccines for autoimmunity
Plus: Regeneron, Mammoth to make CRISPR-based gene editing therapies, and updates from Vertex-TreeFrog, Ono-Deciphera and more
BioCentury | Apr 24, 2024
Deals
AI-guided antibody designer BigHat taps J&J as latest partner as internal pipeline advances
Still years away from the clinic, the biotech now has four deals with larger pharmas that are informing decisions around its wholly-owned programs
BioCentury | Jul 21, 2022
Finance
July 20 Quick Takes: Multiomics-driven cancer newco Auron raises $48M series A
Plus Section 32 leads BigHat’s $75M round; PTC gains first global approval of brain-infused gene therapy; and more
BioCentury | Feb 11, 2021
Emerging Company Profile
BigHat: AI for antibody optimization beyond target engagement
Emerging Company Profile: $19M a16z-led round to support antibody optimization platform
Items per page:
1 - 5 of 5